Neurofilament light chain: defining the analyte

Claire A Leckey; Henrik Zetterberg

doi:10.1093/braincomms/fcac070

Neurofilament light chain: defining the analyte

Brain Commun. 2022 Mar 21;4(2):fcac070. doi: 10.1093/braincomms/fcac070. eCollection 2022.

Authors

Claire A Leckey^{1

2

3}, Henrik Zetterberg^{1

2

4

5

6}

Affiliations

¹ UK Dementia Research Institute at UCL, London, UK.
² Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
³ Centre for Translational Omics, UCL Great Ormond Street Institute of Child Health, London, UK.
⁴ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
⁵ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
⁶ Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.

Abstract

This scientific commentary refers to 'A map of neurofilament light chain species in brain and cerebrospinal fluid and alterations in Alzheimer's disease' by Budelier et al. (https://doi.org/10.1093/braincomms/fcac045).